肺外周病变非诊断性穿刺的恶性风险与CEUS引导价值
多中心回顾性研究纳入1558例患者1591个肺外周病变,经皮穿刺约40%为非诊断性结果。研究发现不同非诊断性病理分类的恶性风险存在差异,CEUS引导可提高取材成功率和诊断准确性,尤其对3.1-5.0cm病变。
要点
- 非诊断性病理中非典型上皮恶性风险最高,非特异性良性最低。
- CEUS引导穿刺对3.1-5.0cm肺外周病变提高取材成功率和诊断效能。
- 非诊断性结果需按病理分类分层管理,避免一概重复穿刺。
核心结论
- 非诊断性PTNB结果中,非典型上皮病变恶性风险最高,非特异性良性病变风险最低。
- CEUS引导PTNB对3.1-5.0cm肺外周病变的取材成功率、诊断准确性和敏感度均显著提高。
研究设计与样本
- 多中心回顾性研究,纳入2018年10月至2023年3月三家机构接受PTNB的1558例患者共1591个肺外周病变。
- PTNB结果分为诊断性(恶性或特异性良性)与非诊断性(非特异性良性、非典型上皮、标本不足或取材失败)。
关键影像表现/征象
- 约40%的PTNB为非诊断性结果。
- 病变越大,恶性风险越高(p<0.001),肉芽肿性炎症/机化性肺炎为保护因素。
- 可疑恶性的非典型细胞较意义不明确的非典型细胞恶性风险更高(p<0.001),标本不足与取材失败的恶性率无显著差异(p>0.05)。
诊断标准与关键数值
- 恶性风险随病变增大而升高(p<0.001),肉芽肿性炎症/机化性肺炎为保护性因素。
- 可疑恶性的非典型细胞恶性风险显著高于意义不明确的非典型细胞(p<0.001)。
- 标本不足与取材失败的恶性率无显著差异(p>0.05)。
- 与非增强US引导相比,CEUS引导取材成功率、诊断准确性、敏感度更高,以3.1-5.0cm病变尤为明显(均p<0.05)。
临床应用与阅片要点
- 报告非诊断性穿刺时,应明确病理亚分类并标注对应的恶性风险层级,指导后续处理决策。
- 对3.1-5.0cm肺外周病变,优先考虑CEUS引导穿刺可减少非诊断性结果和重复操作。
局限性
- 回顾性研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the malignancy risk of peripheral lung lesions with non-diagnostic percutaneous transthoracic needle biopsy (PTNB) findings and to evaluate contrast-enhanced ultrasound (CEUS) guidance for reducing non-diagnostic outcomes.
MATERIALS AND METHODS: This retrospective study included patients who underwent PTNB at three institutions between October 2018 and March 2023. PTNB results were categorized as diagnostic (malignancy or specific benignity) or non-diagnostic (nonspecific benignity, atypical epithelia, insufficient samples, or sampling failure). The risk factors for malignancy and the effectiveness of CEUS for guiding PTNB were analyzed.
RESULTS: This study included 1591 peripheral lung lesions from 1558 patients (median age: 63 y; range: 18-87 y). Among these patients, 1072 were male, and 486 were female. Approximately 40% of PTNBs yielded non-diagnostic results. Malignancy risk increased with increasing lesion size (p < 0.001). Granulomatous inflammation/organizing pneumonia was a protective factor. Compared with atypical cells of undetermined significance, atypical cells suspicious of malignancy conferred a higher malignancy risk (p < 0.001). No significant difference in malignancy rates was observed between insufficient samples and sampling failures (p > 0.05). Compared with non‑contrast enhanced US guidance, CEUS guidance demonstrated a significantly greater sampling success rate, higher diagnostic accuracy, and higher sensitivity, particularly for lesions measuring 3.1-5.0 cm (all p < 0.05).
CONCLUSION: In terms of non-diagnostic PTNB results, lesions with atypical epithelia have the highest malignancy risk, whereas nonspecific benign lesions have the lowest risk. This study suggests that CEUS-guided PTNB is significantly effective for diagnosing lesions ranging from 3.1 to 5.0 cm in size, aiding the selection of imaging guidance.
KEY POINTS: Question What is the malignancy risk in peripheral lung lesions of non-diagnostic PTNB results, and can CEUS guidance effectively improve diagnostic accuracy and reduce inconclusive outcomes? Findings Malignancy risk varies significantly across different non-diagnostic pathological categories, while CEUS guidance demonstrated improved overall diagnostic performance, particularly for lesions measuring 3.1 to 5.0 cm. Clinical relevance This study provides a risk-stratification framework for managing non-diagnostic biopsies and demonstrates that integrating CEUS can optimize sampling success, reduce repeated procedures, and ensure timely, accurate diagnosis for patients with peripheral lung lesions.
引用
- Li, Yan, Nie, et al. Malignancy risk and contrast-enhanced ultrasound guidance in non-diagnostic biopsies of peripheral lung lesions: a multicenter study. Eur Radiol. 2026. PMID: 42525281. doi:10.1007/s00330-026-12763-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。